𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Autonomic cardiovascular function and baroreflex sensitivity in patients with cervical dystonia receiving treatment with botulinum toxin type A

✍ Scribed by D. Tiple; S. Strano; C. Colosimo; G. Fabbrini; G. Calcagnini; M. Prencipe; A. Berardelli


Publisher
Springer
Year
2008
Tongue
English
Weight
256 KB
Volume
255
Category
Article
ISSN
0340-5354

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Comparison of treatment of tardive dysto
✍ Dr. Allison Brashear; Walter T. Ambrosius; George J. Eckert; Eric R. Siemers 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 337 KB

To compare clinical parameters of patients treated with botulinum toxin type A (BTX) for treatment of idiopathic cervical dystonia (ICD) and for tardive cervical dystonia (TCD), we studied 156 patients (149 with ICD and 7 with TCD) who were treated with serial injections of BTX over 5 years. We hypo

Long-term botulinum toxin treatment incr
✍ Inger Marie Skogseid; Jo Røislien; Bjørgulf Claussen; Emilia Kerty 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 153 KB

## Abstract We examined the impact of cervical dystonia (CD) and long‐term botulinum toxin (BTX) treatment on employment status. Data on employment status at onset of CD, at initiation of BTX treatment, and at evaluation of long‐term treatment were obtained from 62 CD patients aged 31–66 years (med

Botulinum toxin type B vs. type A in tox
✍ Eric J. Pappert; Terry Germanson 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 131 KB

## Abstract The objective of this study was to compare efficacy, safety, and duration of botulinum toxin type A (BoNT‐A) and type B (BoNT‐B) in toxin‐naïve cervical dystonia (CD) subjects. BoNT‐naïve CD subjects were randomized to BoNT‐A or BoNT‐B and evaluated in a double‐blind trial at baseline a